Cabergoline-related severe restrictive mitral regurgitation.
Pinero
Antonio
A
Marcos-Alberca
Pedro
P
Fortes
Jose
J
D000368:Aged; D000978:Antiparkinson Agents / Q000009:adverse effects*; D000077465:Cabergoline; D018491:Dopamine Agonists / Q000009:adverse effects*; D004873:Ergolines / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008943:Mitral Valve / Q000000981:diagnostic imaging / Q000473:pathology; D008944:Mitral Valve Insufficiency / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000473:pathology; D010300:Parkinson Disease / Q000188:drug therapy; D014463:Ultrasonography
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D004873:Ergolines; D000077465:Cabergoline